Design, Synthesis and Evaluation of Hesperetin Derivatives as Potential Multifunctional Anti-Alzheimer Agents. 2017

Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, 230000 Hefei, China. AHlibo6812@163.com.

In this study we designed and synthesized a series of new hesperetin derivatives on the basis of the structural characteristics of acetylcholinesterase (AChE) dual-site inhibitors. The activity of the novel derivatives was also evaluated. Results showed that the synthesized hesperetin derivatives displayed stronger inhibitory activity against AChE and higher selectivity than butyrylcholine esterase (BuChE) (selectivity index values from 68 to 305). The Lineweaver-Burk plot and molecular docking study showed that these compounds targeted both the peripheral anionic site (PAS) and catalytic active site (CAS) of AChE. The derivatives also showed a potent self-induced β-amyloid (Aβ) aggregation inhibition and a peroxyl radical absorbance activity. Moreover, compound 4f significantly protected PC12 neurons against H₂O₂-induced cell death at low concentrations. Cytotoxicity assay showed that the low concentration of the derivatives does not affect the viability of the SH-SY5Y neurons. Thus, these hesperetin derivatives are potential multifunctional agents for further development for the treatment of Alzheimer's disease.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006569 Hesperidin A flavanone glycoside found in CITRUS fruit peels. 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-,Hesperidin 2S,Hesperetin 7-Rhamnoglucoside,Hesperetin-7-Rutinoside,2S, Hesperidin,7-Rhamnoglucoside, Hesperetin,Hesperetin 7 Rhamnoglucoside,Hesperetin 7 Rutinoside
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
October 2016, European journal of medicinal chemistry,
Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
November 2023, Bioorganic chemistry,
Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
February 2019, Chemical biology & drug design,
Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
September 2016, Journal of medicinal chemistry,
Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
February 2018, Bioorganic & medicinal chemistry letters,
Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
February 2018, Molecules (Basel, Switzerland),
Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
December 2013, Bioorganic & medicinal chemistry,
Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
August 2020, Bioorganic chemistry,
Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
August 2015, Bioorganic & medicinal chemistry,
Bo Li, and Ai-Ling Huang, and Yi-Long Zhang, and Zeng Li, and Hai-Wen Ding, and Cheng Huang, and Xiao-Ming Meng, and Jun Li
May 2021, ACS chemical neuroscience,
Copied contents to your clipboard!